Combination therapy in cholesterol reduction: focus on ezetimibe and statins

Although widely used in lipid lowering therapy, HMG CoA reductase inhibitors (even when administered at high doses) are frequently insufficient to achieve guideline-recommended LDL-C goals for many patients with hypercholesterolemia in everyday clinical practice. Many patients do not achieve LDL-C g...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigore, Liliana, Norata, Giuseppe Danilo, Catapano, Alberico L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496970/
https://www.ncbi.nlm.nih.gov/pubmed/18561502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496970/
https://www.ncbi.nlm.nih.gov/pubmed/18561502

Ejemplares similares